1. EachPod
EachPod
EHA Unplugged - Podcast

EHA Unplugged

In these EHA-produced podcasts, experts share with you their hematology knowledge and stories. With "EHA Unplugged" we would like to give you the opportunity to unplug from your computer screen, while still learning, by listening to interviews, clinical cases, monologues, and more.

Courses Health & Fitness Medicine Education
Update frequency
every 7 days
Average duration
20 minutes
Episodes
156
Years Active
2021 - 2025
Share to:
Mental Health in CLL

Mental Health in CLL

In this podcast, Prof Dame Lesley Fallowfield and Prof Clemens Wendtner discuss patient mental health and communication in the context of Chronic Lymphocytic Leukemia (CLL) treatment. They explore th…

00:24:54  |   Fri 21 Mar 2025
Patient Perspectives on Gene Therapy for Sickle Cell Disease and B-Thalassemia

Patient Perspectives on Gene Therapy for Sickle Cell Disease and B-Thalassemia

Join us for an insightful interview with patient advocates Miriam Santos Freire (sickle cell disease) and Loris Brunetta (beta-thalassemia major). Benefit from their experiences as they discuss with …

00:27:41  |   Fri 14 Mar 2025
Hematology Portraits: Prof Kostas Stamatopoulos

Hematology Portraits: Prof Kostas Stamatopoulos

Join us for an interview with Prof Kostas Stamatopoulos, as he shares his personal journey as both a medical doctor and a researcher in hematology and understand how these two activities have always …

00:23:34  |   Fri 28 Feb 2025
Management of High-risk MDS: Seeking Clarity for Classification and Treatment

Management of High-risk MDS: Seeking Clarity for Classification and Treatment

This podcast episode is derived from the MDS Algorithm on EHA Campus. Check out the MDS Algorithm, which is an expert based tool for healthcare providers, ensuring a structured and evidence-based app…

00:34:31  |   Fri 14 Feb 2025
Hematopoietic Stem Cells in Health, Aging and Malignancy:  Focus on Metabolism (EHA2024)

Hematopoietic Stem Cells in Health, Aging and Malignancy: Focus on Metabolism (EHA2024)

In this episode on recent insights about metabolism of the hematopoietic stem cells (HSCs), Dr Krzysztof Szade from Jagellonian University in Krakow, Poland, discusses HSPc in health, aging and malig…

00:07:37  |   Fri 07 Feb 2025
Innovative Trial Design (EHA2024)

Innovative Trial Design (EHA2024)

This podcast episode highlights the need to use innovative clinical trial designs in the era of increasingly personalized medicine in hematology. Listen to Dr Jurjen Versluis from Erasmus Medical Cen…

00:17:31  |   Fri 31 Jan 2025
Hereditary Hematological Malignancies (HHMs): A New Era of Discovery in MDS and AML (EHA2024)

Hereditary Hematological Malignancies (HHMs): A New Era of Discovery in MDS and AML (EHA2024)

As knowledge about hereditary hematological malignancies (HHMs) increases, so do the options for better management of these diseases. Please join us in this podcast to hear Dr Kiran Tawana from Adden…

00:22:44  |   Fri 24 Jan 2025
Hairy Cell Leukemia (HCL): Treatment of Relapsed Disease (EHA2024)

Hairy Cell Leukemia (HCL): Treatment of Relapsed Disease (EHA2024)

In this podcast, Prof Thorsten Zenz from University Hospital in Zurich, Switzerland, discusses the current approaches to treatment of relapsed hairy cell leukemia (HCL). Based on his personal journey…

00:17:41  |   Mon 20 Jan 2025
Iron Metabolism in Myelodysplastic Syndrome (MDS)

Iron Metabolism in Myelodysplastic Syndrome (MDS)

In this episode of EHA Unplugged, Prof Kirsten Grønbæk and our guests Prof Yelena Ginzburg and Prof Amit Verma discuss iron metabolism and its role in erythropoiesis in MDS.

The experts share their v…

00:33:18  |   Fri 10 Jan 2025
First-line Treatment of Primary Central Nervous System Lymphoma (PCNSL) (EHA2024)

First-line Treatment of Primary Central Nervous System Lymphoma (PCNSL) (EHA2024)

In this podcast, Dr Elisabeth Schorb from University Medical Center in Freiburg, Germany, discusses the first-line treatment of primary central nervous system lymphoma (PCNSL), which has seen tremend…

00:18:22  |   Fri 27 Dec 2024
Optimizing Global Care for Women with von Willebrand Disease (VWD) (EHA2024)

Optimizing Global Care for Women with von Willebrand Disease (VWD) (EHA2024)

With the increasing scrutiny of healthcare pathways for women, this podcast provides a timely plea by Dr Michelle Lavin from St. James’s Hospital in Dublin, Ireland, to optimize global care for women…

00:22:23  |   Sat 21 Dec 2024
Iron and Infections: Back to the Future (EHA2024)

Iron and Infections: Back to the Future (EHA2024)

In this lecture from EHA2024, Prof Domenico Girelli from University of Verona, Italy, discusses the complex relationship between iron metabolism and infection.

As an essential element for physiology …

00:17:46  |   Fri 13 Dec 2024
Long-term Outcomes in the Chemo-free era for Acute Promyelocytic Leukemia (EHA2024)

Long-term Outcomes in the Chemo-free era for Acute Promyelocytic Leukemia (EHA2024)

Join us for an insightful lecture by Prof Maria Teresa Voso from University of Rome Tor Vergata in Italy, as she discusses the advances in the treatment of a rare subtype of AML, the acute promyelocy…

00:19:09  |   Fri 06 Dec 2024
Thrombotic thrombocytopenic purpura (TTP): Is plasmapheresis history?

Thrombotic thrombocytopenic purpura (TTP): Is plasmapheresis history?

Join us for this engaging debate on the future of acquired TTP (aTTP) treatment chaired by Dr. Eleni Gavriilaki from Aristotle University of Thessaloniki in Greece. This discussion features Prof. Mar…

00:17:19  |   Fri 29 Nov 2024
The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann)

The Role of Artificial Intelligence in Hematology (featuring Dr Gregor Hormann)

Join us in this podcast episode to get a glimpse of what the future holds in the big field of innovation in hematology. With the help of our host, Dr Gregor Hormann (MLL Munich Leukemia Laboratory, G…

00:16:20  |   Fri 22 Nov 2024
From MDS to AML: Genetics of Progression (featuring Prof Lars Bullinger)

From MDS to AML: Genetics of Progression (featuring Prof Lars Bullinger)

Tune in to EHA Unplugged for an engaging chat with Professor Lars Bullinger from Charité University Medicine, Berlin. He'll break down the latest in myeloid disease classification, discussing how new…

00:20:33  |   Mon 18 Nov 2024
Screening for Sickle Cell Disease (with Prof David Rees)

Screening for Sickle Cell Disease (with Prof David Rees)

Join us for an insightful episode featuring Prof David Rees from King’s College Hospital in London as he discusses screening practices for Sickle Cell disease (SCD). Hosted by Dr Sarah de Vlieger, th…

00:17:50  |   Fri 08 Nov 2024
The Environmental Impact on Hematology Practice (with Dr Stephen Hibbs)

The Environmental Impact on Hematology Practice (with Dr Stephen Hibbs)

Join us for an engaging episode with Dr. Stephen Hibbs from Queen Mary University of London as he discusses the environmental impacts of hematology. Alongside our host Dr. Sarah de Vlieger, they expl…

00:12:58  |   Fri 01 Nov 2024
Synthetic Patients: The Future of Clinical Trials?

Synthetic Patients: The Future of Clinical Trials?

Join us in this podcast episode, exploring with Prof Matteo Della Porta (Humanitas Research Hospital, Milano, Italy) the emerging role of "synthetic patients" in hematological clinical trials. Innova…

00:14:45  |   Fri 25 Oct 2024
Innovative tools for Disease Monitoring in Multiple Myeloma

Innovative tools for Disease Monitoring in Multiple Myeloma

Join us for an insightful interview with Prof Bruno Paiva from Clinical University of Navarra in Pamplona, Spain, as he and our host Dr. Isabel Olivera-Martinez, discuss the latest technical approach…

00:18:15  |   Fri 18 Oct 2024
Disclaimer: The podcast and artwork embedded on this page are the property of European Hematology Association. This content is not affiliated with or endorsed by eachpod.com.